50242-127-01 : NDC 2026 Code

50242-127-01 : Glofitamab ( Columvi )

Additionally :

You can get information about “50242-127-01” NDC code in 50242-127-01 in HTML format

HTML | 50242-127-01 in TXT (Plain Text) format

TXT | 50242-127-01 in PDF (Portable Document Format)

PDF | 50242-127-01 in XML format

XML formats.

NDC Code : 50242-127-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50242-127-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-127-01)  / 10 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "50242-0127-01",
    "ProductNDC": "50242-127",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Columvi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Glofitamab",
    "DosageFormName": "CONCENTRATE",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20230615",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761309",
    "LabelerName": "Genentech, Inc.",
    "SubstanceName": "GLOFITAMAB",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/10mL",
    "Pharm_Classes": "Bispecific CD20-directed CD3 T Cell Engager [EPC], CD20-directed Antibody Interactions [MoA], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Cytochrome P450 Inhibitors [MoA], Increased Cytokine Activity [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230615",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}